Inhibitory killer cell immunoglobulin-like receptors strengthen CD8 + T cell–mediated control of HIV-1, HCV, and HTLV-1
Boelen L., Debebe B., Silveira M., Salam A., Makinde J., Roberts CH., Wang ECY., Frater J., Gilmour J., Twigger K., Ladell K., Miners KL., Jayaraman J., Traherne JA., Price DA., Qi Y., Martin MP., Macallan DC., Thio CL., Astemborski J., Kirk G., Donfield SM., Buchbinder S., Khakoo SI., Goedert JJ., Trowsdale J., Carrington M., Kollnberger S., Asquith B.
Inhibitory killer cell immunoglobulin-like receptors (iKIRs) help maintain CD8 + T cell responses to human chronic viral infections.